Cargando…

Yes-associated protein: A novel molecular target for the diagnosis, treatment and prognosis of hepatocellular carcinoma

Hepatocellular carcinoma (HCC) is a common type of malignant tumor. The early-diagnosis and treatment options for HCC are limited, which is primarily due to an incomplete understanding of the underlying molecular mechanisms of the disease. Yes-associated protein (YAP) overexpression promotes prolife...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shan, Liang, Jiang, Hongyuan, Ma, Lifang, Yu, Yongchun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5587989/ https://www.ncbi.nlm.nih.gov/pubmed/28927078 http://dx.doi.org/10.3892/ol.2017.6622

Ejemplares similares

Huaier Restrains Proliferative and Migratory Potential of Hepatocellular Carcinoma Cells Partially Through Decreased Yes-Associated Protein 1
por: Shan, Liang, et al.
Publicado: (2017)

YES, a novel therapeutic target in hepatocellular carcinoma
por: Lapouge, Marjorie, et al.
Publicado: (2022)

Prognostic and clinicopathologic significance of SIRT1 expression in hepatocellular carcinoma
por: Jiang, Hongyuan, et al.
Publicado: (2016)

The Role of MicroRNAs in Hepatocellular Carcinoma
por: Xu, Xin, et al.
Publicado: (2018)

Huaier Augmented the Chemotherapeutic Sensitivity of Oxaliplatin via Downregulation of YAP in Hepatocellular Carcinoma
por: Tao, Yuquan, et al.
Publicado: (2018)

Role of Yes-associated Protein-1 in Gastrointestinal Cancers and Hepatocellular Carcinoma
por: Qian, Xia, et al.
Publicado: (2021)

Increased Expression of Yes-Associated Protein 1 in Hepatocellular Carcinoma with Stemness and Combined Hepatocellular-Cholangiocarcinoma
por: Kim, Gi Jeong, et al.
Publicado: (2013)

The correlation between poor prognosis and increased yes-associated protein 1 expression in keratin 19 expressing hepatocellular carcinomas and cholangiocarcinomas
por: Lee, KyuHo, et al.
Publicado: (2017)

Huaier Suppresses the Hepatocellular Carcinoma Cell Cycle by Regulating Minichromosome Maintenance Proteins
por: Niu, Yongjie, et al.
Publicado: (2020)

Diagnosis, Therapy, and Prognosis for Hepatocellular Carcinoma
por: Ren, Zhigang, et al.
Publicado: (2020)

Doxorubicin induces apoptosis by targeting Madcam1 and AKT and inhibiting protein translation initiation in hepatocellular carcinoma cells
por: Wang, Jiayi, et al.
Publicado: (2015)

TMEM147 is a novel biomarker for diagnosis and prognosis of hepatocellular carcinoma
por: Fan, Wen-Jie, et al.
Publicado: (2023)

Novel molecular targets in hepatocellular carcinoma
por: Chow, Ariel Ka-Man, et al.
Publicado: (2020)

Novel Molecular Targets for Hepatocellular Carcinoma
por: Cavalluzzo, Beatrice, et al.
Publicado: (2021)

Identification and Validation of Novel Biomarkers for Diagnosis and Prognosis of Hepatocellular Carcinoma
por: Hu, Xiaoyi, et al.
Publicado: (2020)

Overexpression of Yes‐associated protein and its association with clinicopathological features of hepatocellular carcinoma: A meta‐analysis
por: Lin, Chengjie, et al.
Publicado: (2017)

A pilot study of Livin gene and Yes-associated protein 1 expression in hepatocellular carcinoma patients
por: Badr, Eman AE., et al.
Publicado: (2019)

Transcription factor glucocorticoid modulatory element-binding protein 1 promotes hepatocellular carcinoma progression by activating Yes-associate protein 1
por: Chen, Cheng, et al.
Publicado: (2023)

α-Hederin Inhibits the Proliferation of Hepatocellular Carcinoma Cells via Hippo-Yes-Associated Protein Signaling Pathway
por: Chen, Tongqing, et al.
Publicado: (2022)

Yes-associated protein expression is associated with poor prognosis in patients with colorectal cancer
por: Cao, Liyu, et al.
Publicado: (2021)

Reactive oxygen species-induced activation of Yes-associated protein-1 through the c-Myc pathway is a therapeutic target in hepatocellular carcinoma
por: Cho, Yuri, et al.
Publicado: (2020)

Yes-associated protein-1 may serve as a diagnostic marker and therapeutic target for residual/recurrent hepatocellular carcinoma post-transarterial chemoembolization(☆)
por: Qian, Xia, et al.
Publicado: (2020)

Corrigendum: Identification and Validation of Novel Biomarkers for Diagnosis and Prognosis of Hepatocellular Carcinoma
por: Hu, Xiaoyi, et al.
Publicado: (2020)

Molecular Determinants of Prognosis in Hepatocellular Carcinoma
por: Nault, Jean-Charles
Publicado: (2014)

Noninvasive imaging of hepatocellular carcinoma: From diagnosis to prognosis
por: Jiang, Han-Yu, et al.
Publicado: (2018)

Yes
por: Stanley, Arthur
Publicado: (1923)

miR-125a-5p inhibits tumorigenesis in hepatocellular carcinoma
por: Xu, Xin, et al.
Publicado: (2019)

A novel microRNAs expression signature for hepatocellular carcinoma diagnosis and prognosis
por: Lu, Mengxuan, et al.
Publicado: (2017)

Targeting Yes1 Associated Transcriptional Regulator Inhibits Hepatocellular Carcinoma Progression and Improves Sensitivity to Sorafenib: An in vitro and in vivo Study
por: Guo, Liwen, et al.
Publicado: (2020)

LncRNA-ATB promotes autophagy by activating Yes-associated protein and inducing autophagy-related protein 5 expression in hepatocellular carcinoma
por: Wang, Chuan-Zhuo, et al.
Publicado: (2019)

Novel Molecular Targets for Immune Surveillance of Hepatocellular Carcinoma
por: Guerra, Pietro, et al.
Publicado: (2023)

Yes-associated protein (YAP) binds to HIF-1α and sustains HIF-1α protein stability to promote hepatocellular carcinoma cell glycolysis under hypoxic stress
por: Zhang, Xiaodong, et al.
Publicado: (2018)

Exosomal miR-665 as a novel minimally invasive biomarker for hepatocellular carcinoma diagnosis and prognosis
por: Qu, Zhen, et al.
Publicado: (2017)

Time Dependency of Molecular Evolutionary Rates? Yes and No
por: Subramanian, Sankar, et al.
Publicado: (2011)

A novel molecular-clinicopathologic nomogram to improve prognosis prediction of hepatocellular carcinoma
por: Zhang, Zhongjing, et al.
Publicado: (2020)

Identification of novel lactate metabolism signatures and molecular subtypes for prognosis in hepatocellular carcinoma
por: Guan, Qiutong, et al.
Publicado: (2022)

Yes-Associated Protein 1 Is a Novel Calcium Sensing Receptor Target in Human Parathyroid Tumors
por: Tavanti, Giulia Stefania, et al.
Publicado: (2021)

Considerations regarding current diagnosis and prognosis of hepatocellular carcinoma
por: Cristea, CG, et al.
Publicado: (2015)

Exosome Cargos as Biomarkers for Diagnosis and Prognosis of Hepatocellular Carcinoma
por: Zeng, Yulai, et al.
Publicado: (2023)

Bioinformatics screening the novel and promising targets of curcumin in hepatocellular carcinoma chemotherapy and prognosis
por: Yang, Tingting, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_umcrjslcmdnbj1g39m097e52uk